Avid Bioservices to be sold to private equity firms for $1.1B

After a year of customer pullbacks, biologics CDMO Avid Bioservices will be taken private by GHO Capital Partners and Ampersand Capital Partners in a deal worth $1.1 billion. “In evaluating this transaction, our Board considered ...